Bristol-Myers Squibb faces patent risks but has promising new drugs. Find out why BMY stock remains a "Buy" with strong ...

As the Federal Reserve prepares to meet next week for the final time in 2024, analysts are broadly predicting one last rate cut to close out the year.

The dollar surged to a two-year high, fueled by hawkish U.S. interest rate projections, while the yen plummeted to a new low. Several currencies, including the South Korean won and Canadian dollar, ...